IRIX Q1 2026 Earnings NarrowerthanExpected Loss Signals Operational Discipline Instil Bio Q1 2026 Earnings EPS Miss as DevelopmentStage Company Reports No Revenue Stock Edges Up CHA Q4 2025 Earnings Significant EPS Miss Sends Shares Lower Amid Broader Challenges SWKH Q3 2025 Earnings Strong EPS Beat Driven by Investment Gains and Portfolio Performance TYRA Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues RD Investment ALRM Q1 2026 Earnings EPS Beats Estimates by 54 Stock Edges Higher